VITAL

Vital Chemtech Limited

Listed company · ISIN INE0L4K01016 · NSE EQ · FV ₹10
Last price
₹55
+4.74%today
What this company does

Vital Chemtech Limited is a listed company. It booked ₹51 cr of revenue in its latest quarter (Q1 FY27) and kept 4.8% of sales as profit.

60out of 100
Equitytale Health Score
Mixed

Healthier than 60% of listed companies we score, on the 5 of 6 measures we could read for it. Each measure is ranked against the 2,327–2,858 companies that reported it.

Measures financial condition, not whether to buy. Learn what this score means · How this is calculated

Price momentum
neutral
RSI (14)
55

At close. Not part of the score.

Profitability & returns41

How much profit it earns on the money it employs

Balance sheet33

How much it owes, and whether earnings cover the interest

Cash quality91

Whether reported profit actually arrives as cash

Valuation71

What today's price implies, against our models or its peers

Governance & risk100

How much of the promoters' stake is pledged, and how much they hold · highest in its sector on what we could measure

Not measurable for this company: growth & consistency. Those pillars are left out of the score rather than counted as zero.

Is this company doing well?
not investment advice
A mixed picture
Strengths
Makes a profit
Promoters hold 73%
No promoter shares pledged
Watch-outs
! Thin 4.8% net margin

What if I invest in VITAL?

Set a growth rate and see what a monthly SIP would add up to. Your assumption, our arithmetic.

You would put in
₹12.00 lakh
120 instalments
At 10% a year, it would become
₹20.15 lakh

The starting rate is a round number, not a view on this company — this is your assumption, and the figure above is arithmetic on it. Returns are not steady year to year, and a real holding would not grow in a straight line. We do not publish price targets or predict returns.

Key ratios · latest quarter + price
₹55 +4.74%
latest close · 2026-09-17
52-wk low ₹4642 sessions so far52-wk high ₹59
Is it cheap or expensive?
What you pay for the profits, book value and cash flow. Higher isn't automatically worse — it can signal faster growth.
P/E ratio12.8Low
LowAverageHigh
P/B ratio1.33Moderate
Below bookModerateHigh
EV / EBITDA7.8Low
LowAverageHigh
How good is the business?
How much profit it earns from its money and its sales.
Return on equity9.9%Fair
WeakFairStrong ▸15%
Return on capital12.3%Fair
WeakFairStrong
Net margin4.8%Thin
ThinDecentStrong
EBITDA margin12.2%Decent
ThinDecentHealthy
Is it financially safe?
How much it owes, and whether it can comfortably cover it.
Debt to equity0.62Moderate
LowModerateHigh ▸1
Interest cover4.4×Okay
RiskyOkayStrong ▸5×
Current ratio1.20Healthy
Tight ◂1HealthyAmple
More figures
Market cap
₹132 cr
Book value
₹41
EPS
₹1.08
latest quarter
Net debt
₹61 cr
owes more than its cash
Enterprise value
₹193 cr
EBITDA
₹25 cr
annualised
EBIT
₹18 cr
annualised
Operating margin
8.7%
Return on assets
4.5%
Earnings yield
7.83%
P/S
0.65
Sales / share
₹85.5
Tax rate
24.6%
Face value
₹10
Shares
2.4 cr
Working capital
₹15 cr
Current assets
₹90 cr
Current liabilities
₹75 cr
Delivery %
95.1%
Strong / safeFairWeak / riskyValuation — a level, not good/badBands are general rules of thumb, not advice.

P/E, ROE, ROCE and margins are annualised from the latest quarter; per-share and balance-sheet ratios use the most recent balance sheet on file · prices as of 2026-09-17.

Worth vs price · from the exchange filings
not investment advice
Hard to value confidentlyLow confidence
Too few reliable models — the filings don't support two independent estimates of value.
Models span ₹20₹20, midpoint ₹20

An educational model from the company's own filings, every assumption shown — not investment advice or a price target. Prices can stay above or below any model for years.

P&L · Q1 FY27 (consolidated)
Revenue from Operations₹51 cr
Other Income₹13 L
Total Income₹51 cr
Cost of Materials₹41 cr
Purchases of Stock-in-Trade₹0 cr
Inventory Change (±)₹-3 cr
Employee Benefit Expense₹3 cr
Finance Costs₹1 cr
Depreciation & Amortisation₹2 cr
Other Expenses₹4 cr
Total Expenses₹48 cr
Profit before Tax₹3 cr
Tax Expense₹84.5 L
Net Profit₹3 cr
Net margin on total income5.0%
Where the money goes · Q1 FY27
% of total income
Materials + stock-in-trade₹38 cr73.7%
Employee benefit expense₹3 cr5.8%
Finance costs₹1 cr2.0%
Depreciation & amortisation₹2 cr3.5%
Other expenses₹4 cr8.4%
Tax expense₹84.5 L1.6%
Profit for the period₹3 cr5.0%
Total income ₹51 cradds up to ₹100 ✓
Quarterly results · consolidated (₹ cr)
MetricQ4 FY26Q1 FY27
Revenue35 cr51 cr
Total income35 cr51 cr
Expenses34 cr48 cr
Profit before tax96.2 L3 cr
Tax11.9 L84.5 L
Net profit (owners' share)84.3 L2 cr
Net margin (owners' share, on revenue)2.4%4.8%
EPS (₹)0.361.08
Balance sheet & cash flow · as of Mar 2026
Moderate debt
Total assets
₹219 cr
Shareholder equity
₹99 cr
parent shareholders
Total debt
₹62 cr
Cash
₹88.2 L
Who owns it · 2026-06-30
No pledge
Promoter
73.4%
FII / Foreign
1.6%
DII / Domestic
0.3%
Retail / others
24.7%
Promoter stake up 0.2% over the last 9 quarters.
Smart-money activity
Insider trades
BoughtVipul Bhatt · Promoters36,000 · ₹27.7 L31 Mar 23
BoughtVipul Bhatt · Promoters36,000 · ₹27.7 L31 Mar 23
Bulk / block deals
SoldV JOSHI IMPEX PRIVATE LIMITED · NSE1.20 L @ ₹70.519 Feb 25
BoughtCRAFT EMERGING MARKET FUND PCC- ELITE CAPITAL FUND · NSE1.20 L @ ₹70.519 Feb 25
SoldV JOSHI IMPEX PRIVATE LIMITED · NSE1.30 L @ ₹76.512 Feb 25
Stake changes
BoughtVipul Bhatt · promoter→ 55.11% · 36,00031 Mar 23
What shareholders were asked to approve

A company cannot decide everything on its own. Things like a top executive’s pay, issuing new shares, or re-appointing a director have to be put to the people who own the company, and they vote — one vote per share. So whoever owns the most shares has the most say.

Postal ballot · 21 Dec 2025
See the official result
1
To approve the migration of listing/trading of equity shares of the company from emerge platform of National Stock Exchange of India Limited (‘NSE’) to main board of National Stock Exchange of India Limited (‘NSE’) as well as on main board of BSE Limited (‘BSE’).
Backed by 100% of shareholders other than promotersneeded 75%
6.16 L votes for, 0 against · 0% of mutual funds and other big investors said no

Every vote count above is taken from the result the company filed with the stock exchange, certified by an independent counter. To work out what would have happened without the promoters, we simply remove their votes and re-apply the same legal bar the proposal had to clear. Nothing here is an estimate or an opinion.

Who controls this company, and what it pays them

Most Indian companies are controlled by a family or group — the promoters. The exchange requires them to be listed by name, including members who own no shares at all, and requires the company to disclose any business it does with them.

The promoter group — 29 named members
owning 73.4% between them · as of 2026-06-30
VIPUL BHATT55.11%
SANGEETA VIPUL BHATT18.32%
Aarti Hitesh Bhattno shares
Ambica Packaging Industriesno shares
Chhaya Akshay Pandyano shares
DHAVAL HASMUKHBHAI PANDYAno shares
Harshadrai Pranlal Trivedino shares
Harsha Jaladhi Trivedino shares
Business done with them
FY2025 · 5 of the group
The company paid ₹28.1 L to companies in the promoter group last year — about 0.2% of its ₹134 cr revenue and received ₹16.3 L back from them.
Vital Synthesis Limited
Advances Given During Year · Loan Received, Loan paid, Sales, Purchases
₹18 cr
company received
Vital Synthesis Limited
Advances Taken During Year · Loan Received, Loan paid, Sales, Purchases
₹10 cr
company received
Vital Alkoxides Private Limited
Advances Given During Year · Loan Received, Loan paid, Sales, Purchases
₹9 cr
company received
Vital Alkoxides Private Limited
Advances Taken During Year · Loan Received, Loan paid, Sales, Purchases
₹8 cr
company received
VITAL WELLNESS LIMITED
Advances Taken During Year · Loan Received, Loan paid
₹2 cr
company received
VITAL WELLNESS LIMITED
Advances Given During Year · Loan Received, Loan paid
₹2 cr
company received
SANGEETA VIPUL BHATT
Advances Given During Year · Directors Remuneration, Loan paid
also owns 18.32% of the company
₹1 cr
company received
Vital Alkoxides Private Limited
Bought goods from them · Loan Received, Loan paid, Sales, Purchases
₹28 L
company paid
Valentia Synthesis Private Limited
Advances Taken During Year · Loan Received, Loan paid
₹23 L
company received
Valentia Synthesis Private Limited
Advances Given During Year · Loan Received, Loan paid
₹23 L
company received
Vital Alkoxides Private Limited
Sold goods to them · Loan Received, Loan paid, Sales, Purchases
₹10.7 L
company received
Vital Synthesis Limited
Sold goods to them · Loan Received, Loan paid, Sales, Purchases
₹5.6 L
company received
Vital Synthesis Limited
Bought goods from them · Loan Received, Loan paid, Sales, Purchases
₹0.04 L
company paid

The company also transacted with 1 other related parties — subsidiaries, joint ventures, directors and others — that we could not match by name to the promoter list above. Some may still be connected to the family; we only count the ones the filings let us match with certainty.

Names and holdings from the company’s shareholding pattern filed with the exchange; transactions from the related-party note in its annual report. Every figure is as filed — these are legal, disclosed dealings, and what to make of them is your call.

How the stock has moved · adjusted for splits & bonuses
Data from primary exchange filings · analysis tool, not investment advice.